230 likes | 922 Views
Questions and Answers Vitrase Integrated Phase III Data PDR as Reason for Hemorrhage Any Laser Therapy Prior to Vitrectomy Vit-02 Recurrent Vitreous Hemorrhage All Incidents (Severity) Vitrase Integrated Phase III Data Reduction in Hemorrhage Density by 3 Months (Screening Lens Status)
E N D
Vitrase Integrated Phase III Data PDR as Reason for Hemorrhage Any Laser Therapy Prior to Vitrectomy
Vit-02 Recurrent Vitreous Hemorrhage All Incidents (Severity)
Vitrase Integrated Phase III Data Reduction in Hemorrhage Density by 3 Months (Screening Lens Status)
Vitrase Integrated Phase III Data Achieved BCVA of LogMAR 1.0 or BetterCumulative Percentages
Vit 02 – North America Achieved BCVA of LogMAR 1.0 or BetterCumulative Percentages
Vit 03 – Ex North America Achieved BCVA of LogMAR 1.0 or BetterCumulative Percentages
Vit-02 Retinal Detachment (Type of Detachment)
Vit-03 Retinal Detachment (Type of Detachment)
Vitrase Integrated Phase III Data Retinal Detachment Prior to Vitrectomy(Time to Diagnosis)
Vitrase Integrated Phase III Data Hypopyon Duration
Vitrase Integrated Phase III Data Iritis by Reduction in Hemorrhage Density
Vitrase Integrated Phase III Data Reduction in Hemorrhage Densityby Iritis
Vitrase Integrated Phase III Data Improvement in BCVALife Table Analysis
Vitrase Integrated Phase III Data Retinal Detachment After and Prior to Vitrectomy
Vit 02 – North America Retinal Detachment After and Prior to Vitrectomy
Vit 03 – Ex North America Retinal Detachment After and Prior to Vitrectomy
Vitrase Integrated Phase III Data Retinal Detachment(Time to Diagnosis)
Vit 02 – North America Retinal Detachment(Time to Diagnosis)
Vit 03 – Ex North America Retinal Detachment(Time to Diagnosis)